Wenger Vieli acted as Swiss legal advisor to NLS Pharmaceutics on the deal. NLS Pharmaceutics completed the direct offering and concurrent private placement transaction with certain...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Mobil in Time on the deal. Mobil in Time, a leader in mobile energy solutions and expert in water damage restoration, has completed...
You must be a Standard 1 Year member to access this content.
Wenger Vieli acted as Swiss legal advisor to NLS Pharmaceutics on the issuance. NLS Pharmaceutics has completed the registered direct offering and concurrent private placement transaction with...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Basellandschaftliche Kantonalbank on obtaining a licence as fund manage-ment company for its subsidiary. BLKB Services, a newly established subsidiary of Basellandschaftliche Kantonalbank, has...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Rapidata on the latest financing round. Wenger Vieli advised Rapidata, a provider of large-scale human data processing to power the future of AI,...
You must be a Standard 1 Year member to access this content.
Niederer Kraft Frey advised L-GAM on the deal. Vischer advised the seller. Wenger Vieli advised the shareholders of Cotta Collection. L-GAM, a mid-market private equity investment...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised neon on the deal. neon is an up-and-coming Swiss fintech that has been serving as many as over 130,000 clients already. neon was...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised NLS Pharmaceutics on the deal. NLS Pharmaceutics Ltd., a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Xeltis AG on the deal. The Chinese company Grand Pharmaceutical Group Ltd (0512.HK) has committed to invest €15 million in equity and license...
You must be a Standard 1 Year member to access this content.
